Trials / Completed
CompletedNCT06857318
Colostrum From MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - a Placebo-controlled Randomized Trial.
Colostrum From MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - From Lab to Human- a Placebo Controlled Randomized Trial.
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to study the efficacy of colostrum from MERS-CoV-positive camels applied as a nasal spray to COVID-19 patients for treatment and prevention of SARS-CoV-2 infection. This study will compare the usage of colostrum to placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Colostrum Nasal Spray | 24 hours use of nasal spray of colostrum from MERS-CoV positive camels- 6 doses total |
| OTHER | Water for injection | 24 hours use of a nasal spray of water for injection- 6 doses total |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2023-08-31
- Completion
- 2024-01-01
- First posted
- 2025-03-04
- Last updated
- 2025-03-04
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT06857318. Inclusion in this directory is not an endorsement.